HomeNewsTrendsCOVID-19 test positivity rate shoots over 10% in 144 districts; watching hospitalisation, death patterns in states, says govt

COVID-19 test positivity rate shoots over 10% in 144 districts; watching hospitalisation, death patterns in states, says govt

In some districts in the northeast, the test positivity rate is as high as 60-100 percent, according to data from the Union health ministry

August 10, 2022 / 16:23 IST
Story continues below Advertisement
(Image: Reuters)
(Image: Reuters)

The COVID-19 test positivity rate (TPR) in 144 districts in India has breached the 10 percent mark yet again while 159 districts are reporting a positivity rate between 5 percent and 10 percent.

As per the World Health Organisation, a TPR of under 5 percent is a sign of the pandemic being under control, and adequate public health measures are recommended for districts falling beyond this category.

Story continues below Advertisement

On August 10, India reported 16,047 new coronavirus cases, which was more than 25 percent higher than the previous day, and 54 new deaths which included 6 backlog fatalities. The total number of active cases, however, dropped by over 3,500. The highest TPRs are being reported from several districts in Andhra Pradesh, Arunachal Pradesh, Assam, Delhi, Haryana, Kerala and Mizoram.

Delhi on Tuesday registered 2,495 new cases and a TPR of 15.41 percent, the highest since January this year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show